Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 2/20 | 0.40 |
| ▸ | NOS3 | P29474 | 2/20 | 0.36 |
| ▸ | NOS1 | P29475 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.33 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.33 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.32 |
| ▸ | PLK1 | P53350 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.31 |
| ▸ | GRM5 | P41594 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27134521 | 0.86 | ACACB (0.36) | ACACBNOS3NOS1GABRA1GABRG2 | |
| SCHEMBL1306384 | 0.83 | GABRA1 (0.38) | ALDH1A1GABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL10300058 | 0.81 | ACACB (0.52) | ACACBNOS3NOS1ALDH1A1SLC6A4 | |
| SCHEMBL20681670 | 0.81 | ACACB (0.52) | ACACBNOS3NOS1ALDH1A1SLC6A4 | |
| SCHEMBL1306505 | 0.81 | APP (0.41) | ALDH1A1GABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL24919969 | 0.79 | MAOA (0.53) | ALDH1A1GABRA1GABRG2GABRB3GABRA5 | |
| SCHEMBL4252316 | 0.78 | KDM4E (0.38) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL29169050 | 0.78 | SLC6A4 (0.38) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL27214767 | 0.77 | ACACB (0.42) | ACACBNOS3NOS1ALDH1A1SLC6A4 | |
| SCHEMBL2854252 | 0.77 | CYP1A1 (0.44) | GABRA1GABRG2GABRB3GABRA5GABRA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023027630-A9 | A FLOW REACTOR, METHODS OF FABRICATION AND REACTIONS THEREOF | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2023-07-27 | — | — | WO | claimed |
| WO-2023027630-A2 | A FLOW REACTOR, METHODS OF FABRICATION AND REACTIONS THEREOF | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2023-03-02 | — | — | WO | claimed |
| US-20250264649-A1 | HIGH REFRACTIVE INDEX AND HIGHLY BIREFRINGENT SOLID ORGANIC MATERIALS | META PLATFORMS TECH LLC (US) | 2025-08-21 | — | — | US | disclosed |
| US-12320999-B2 | High refractive index and highly birefringent solid organic materials | META PLATFORMS TECHNOLOGIES, LLC (US) | 2025-06-03 | — | — | US | disclosed |
| EP-4330736-A1 | HIGH REFRACTIVE INDEX AND HIGHLY BIREFRINGENT SOLID ORGANIC MATERIALS | META PLATFORMS TECHNOLOGIES, LLC (US) | 2024-03-06 | — | — | EP | disclosed |
| CN-117203556-A | High refractive index and high birefringence solid organic material | 元平台技术有限公司 | 2023-12-08 | — | — | CN | disclosed |
| US-20230365543-A1 | MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF USE THEREOF | FORESEE PHARMACEUTICALS USA, INC. | 2023-11-16 | — | — | US | disclosed |
| WO-2023027630-A9 | A FLOW REACTOR, METHODS OF FABRICATION AND REACTIONS THEREOF | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2023-07-27 | — | — | WO | disclosed |
| US-11673884-B2 | Matrix metalloproteinase (MMP) inhibitors and methods of use thereof | Foresee Pharmaceuticals Co., Inc. (TW) | 2023-06-13 | — | — | US | disclosed |
| WO-2023027630-A2 | A FLOW REACTOR, METHODS OF FABRICATION AND REACTIONS THEREOF | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2023-03-02 | — | — | WO | disclosed |
| WO-2022232071-A1 | HIGH REFRACTIVE INDEX AND HIGHLY BIREFRINGENT SOLID ORGANIC MATERIALS | META PLATFORMS TECHNOLOGIES, LLC (US) | 2022-11-03 | — | — | WO | disclosed |
| US-20220342132-A1 | HIGH REFRACTIVE INDEX AND HIGHLY BIREFRINGENT SOLID ORGANIC MATERIALS | FACEBOOK TECHNOLOGIES, LLC | 2022-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230365543-A1 | MATRIX METALLOPROTEINASE (MMP) INHIBITORS AND METHODS OF USE THEREOF | MMP12, MMP1, MMP11 | ACACB 2116/4885NOS3 917/4885NOS1 798/4885 |
| US-11673884-B2 | Matrix metalloproteinase (MMP) inhibitors and methods of use thereof | MMP12, MMP1, MMP11 | ACACB 1997/4885NOS3 765/4885NOS1 518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.